In December 2018, an Italian company, Corvelva, did a safety study on the Infanrix Hexa vaccine which is given to babies in the US at 2, 4, and 6 months according to the CDC recommended schedule, as TDaP.
This is the shocking results of that study:
Corvelva, December 16, 2018
In Infanrix Hexa we found
chemical contamination from the manufacturing process or cross-contamination with other manufacturing lines;
bacterial peptide toxins;
insoluble and indigestible macromolecule that reacts to the protein assay, but cannot be recognized by any protein databases.
We have not found:
Protein antigens of diphtheria toxoids, tetanus, pertussis, hepatitis B, haemophylus influenzae B, Poliomyelitis 1-2-3;
Formaldehyde and glutaraldehyde, phenoxyethanol, antibiotic residues indicated in the composition;
“Not only vaccine antigens have been not detected, there were also 65 signs of chemical contaminants of which only 35% is known, there are among these various processing residues and cross-contaminations from other manufacturing lines, and their identification will be checked during the second level of the analytical study (i.e. with standard controls).
7 chemical toxins among these signals have also been identified, probably deriving from chemical contaminants of the manufacturing process or other manufacturing lines at the vaccine manufacturing site; these toxins have a structure that could probably be partially derived from the formaldehyde, glutaraldehyde and cyanogen bromide reaction with other chemical contaminants in the vaccine. We’d like to point out that the toxicity of many of these toxins have been confirmed and published in Pubchem or Toxnet and this poses important safety problems, issues and concerns.
From the protein and peptide fraction study, various free peptides of bacterial origin have been obtained probably coming from the bacterial culture cells used for the antigen extraction. Literature reports bacterial peptides as potential allergens 5 and also as capable of inducing autoimmune reactions 6 and these too put a safety issue that needs to be further clarified with the regulatory bodies.
Coming back to the two basic principles that have been our topic on this analysis path, we reaffirm what we have said in the recent interview on the scientific journal Nature: we are inquiring the vaccines efficacy and safety and we can’t quite understand how it is possible to claim that this vaccine is even able to generate the 6 protective antibodies – reason why it is designed for – and furthermore to understand how this cluster made of 6 neurotoxic antigens bound together can be claimed as not toxic for newborns.
Infanrix Hexa hexavalent, as for the method we have commissioned, casts major doubts on both its effectiveness and on its safety
The study translated from Italian to English by Corvelva can be downloaded at this url: https://www.corvelva.it/it/speciali-corvelva/analisi/vaccingate-initial-results-on-infanrix-hexa-chemical-composition.html
If at any time in the future that link does not work for the download you can find it on the wayback machine at https://web.archive.org/web/20190527122451/https://drive.google.com/file/d/128CfYaaJdMwhx5yvCGDRggl5GIKyfWrC/view
Disclaimer: Information provided on this website is for informational purposes only and should not be construed as medical or legal advice.